Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects

Part of paid clinical trials in Rogers, Arkansas.

Sponsor
Organon and Co
Study ID
NCT05172726
Phase
PHASE3
Status
Active Not Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
2 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an open-label, multi-center, Phase 3 study to evaluate tapinarof cream, 1% in pediatric subjects with plaque psoriasis.

Key Dates

Start date
Dec 2, 2021
Status verified
Dec 2025
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
58 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Open Label

Primary Outcome Measure

Adverse Events (AEs) and Serious Adverse Events (SAEs) [ Time Frame: Screening up to Week 53 ]

Locations (12)

FacilityCityStateZIPSite coordinators
Northwest Arkansas Clinical Trials Center, PLLCRogersArkansas72758-
First OC DermatologyFountain ValleyCalifornia92708-
Mission Dermatology CenterRancho Santa MargaritaCalifornia92688-
RM Medical ResearchMiami LakesFlorida33014-
San Marcus Research Clinic, Inc.Miami LakesFlorida33014-
Olympian Clinical ResearchTampaFlorida33615-
Northwestern University Feinberg School of MedicineChicagoIllinois60611-
Dawes Fretzin Clinical Research GroupIndianapolisIndiana46250-
Options Research GroupWest LafayetteIndiana47906-
Wright State Physicians Pharmacology Translational UnitFairbornOhio45324-
Oregon Dermatology & Research CenterPortlandOregon97210-
Dermatology Specialists of SpokaneSpokaneWashington99202-

Find similar trials in Rogers, AR

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Northwest Arkansas Clinical Trials Center, PLLC· Rogers, ARFirst OC Dermatology· Fountain Valley, CAMission Dermatology Center· Rancho Santa Margarita, CARM Medical Research· Miami Lakes, FLSan Marcus Research Clinic, Inc.· Miami Lakes, FLOlympian Clinical Research· Tampa, FL

Related Studies